Kronox Lab Sciences Limited has informed the Exchange that Board of Directors at its meeting held on May 21, 2026, recommended Final Dividend of Rs. 0.5 per equity share.
KRONOX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kronox Lab Sciences reported FY2026 audited results with total income of Rs. 10,641.40 Lacs (up 3.6% YoY) and PAT of Rs. 2,766 Lacs (up 8.7% YoY). Revenue from operations grew marginally to Rs. 10,122 Lacs vs Rs. 10,018.4 Lacs in prior year. EPS improved to Rs. 7.51 from Rs. 6.81. The Board recommended a final dividend of Rs. 0.50 per share (5% on face value of Rs. 10). Statutory auditors Mahesh Udhwani & Associates issued an unmodified opinion, confirming clean financial statements. Operating cash flow remained healthy at Rs. 2,389.25 Lacs despite working capital adjustments. The company operates in a single segment - manufacturing of high purity specialty fine chemicals.
The company delivered steady profit growth with EBITDA margin expansion, while maintaining a clean audit opinion. The modest dividend payout signals confidence in cash generation, though the marginal revenue growth may limit near-term re-rating potential.